Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100

D R Illingworth1, F Vakar, R W Mahley

  • 1Department of Medicine, Oregon Health Sciences University, Portland 97201-3098.

PubMed

Insights

Familial defective apolipoprotein B-100 (FDB) is a genetic condition causing high cholesterol. Lovastatin treatment effectively lowered LDL cholesterol in FDB patients, suggesting statins are a viable treatment option.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant disorder.
  • It is characterized by hypercholesterolemia due to a specific amino acid substitution in apoprotein B-100.
  • This substitution results in low-density lipoprotein (LDL) particles with impaired binding to LDL receptors.

Purpose of the Study:

  • To evaluate the efficacy of lovastatin in treating hypercholesterolemia in patients with FDB.
  • To determine the dose-dependent response to lovastatin in this patient population.

Main Methods:

  • A study involving 12 hypercholesterolemic patients from 10 unrelated families with FDB.
  • Patients were treated with either 20 mg or 40 mg of lovastatin daily.
  • Plasma LDL cholesterol levels were measured before and after treatment.

Main Results:

  • Treatment with 20 mg of lovastatin daily resulted in a 21.5% decrease in LDL cholesterol.
  • A higher dose of 40 mg daily led to a more significant reduction of 32.1% in LDL cholesterol.
  • Both dosages showed a positive impact on hypercholesterolemia in FDB patients.

Conclusions:

  • Hypercholesterolemia associated with FDB can be effectively managed with statin therapy.
  • Lovastatin demonstrates a dose-dependent efficacy in reducing LDL cholesterol levels in FDB patients.
  • These findings support the use of statins as a therapeutic strategy for FDB.

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...